U.S. Home Hemodialysis Machines Market to $1.06B by 2035

Market Outlook

By 2035, the U.S. Home Hemodialysis Machines Market is projected to reach approximately USD 1.06 billion, expanding at a CAGR of 13.84% during 2026–2035. The market is estimated at approximately USD 0.29 billion in 2025, following historical expansion from approximately USD 0.18 billion in 2021, USD 0.20 billion in 2022, USD 0.23 billion in 2023, and USD 0.26 billion in 2024. Values in this report are expressed in USD billions.

The U.S. home hemodialysis machine industry is entering a structurally different phase from the broader dialysis equipment market. Historically, home hemodialysis was constrained by machine complexity, water requirements, caregiver dependence, lengthy training, limited patient awareness, nephrologist familiarity, and the institutional dominance of three-times-weekly in-center dialysis. These barriers have not disappeared, but machine architecture, digital guidance, cartridge-based fluid management, integrated water purification, remote monitoring, and value-based kidney care are progressively changing the economics of treating selected dialysis patients at home.

The addressable clinical population remains substantial. More than 800,000 Americans are living with end-stage kidney disease, and dialysis remains the dominant renal replacement therapy among patients without a functioning transplant. The much larger chronic kidney disease population provides a continuing upstream pipeline of patients who may ultimately require renal replacement therapy. Diabetes, hypertension, cardiovascular disease, obesity, population aging, and delayed CKD recognition continue to influence progression to kidney failure.

Home hemodialysis itself remains underpenetrated relative to in-center dialysis. This creates a fundamentally different growth profile from mature dialysis-machine categories. Rather than depending primarily on replacement cycles, the home machine market can expand through conversion of existing in-center patients, increased selection of home therapy among incident dialysis patients, improved patient retention, new home-capable machines, and broader provider investment in transitional care and modality education.

The economic proposition is equally important. Home hemodialysis can reduce dependence on fixed-chair capacity and potentially allow dialysis organizations to support patient growth without equivalent expansion of conventional treatment stations. For integrated providers, the decision to expand home programs therefore involves more than equipment acquisition. It affects nursing allocation, training infrastructure, logistics, technical support, consumable delivery, water management, remote oversight, hospitalization exposure, patient retention, and facility capital requirements.

The market is expected to accelerate as manufacturers compete to reduce the operational burden historically associated with home dialysis. Compact physical footprints, touchscreen guidance, simpler disposable loading, automated priming, integrated water treatment, cloud connectivity, remote treatment records, guided troubleshooting, and lower maintenance intensity are increasingly becoming purchasing criteria.

The competitive environment is also broadening. Fresenius Medical Care through NxStage remains deeply established in U.S. home hemodialysis, but Outset Medical’s Tablo and Quanta’s home-cleared dialysis platform are creating a more credible multi-platform market. Competition through 2035 will therefore increasingly center on patient retention, training time, total cost per successful home patient, treatment flexibility, service reliability, and the ability to integrate home therapy into enterprise kidney-care strategies.

Introduction

According to the U.S. Home Hemodialysis Machines Market Report, home hemodialysis machines represent a specialized portion of the renal replacement technology landscape designed to enable chronic hemodialysis outside conventional dialysis clinics. The category includes purpose-built portable home systems, compact machines capable of operating across care settings, integrated water-purification platforms, cartridge-based dialysis systems, and selected conventional machines configured and cleared for home use.

Home hemodialysis differs commercially from in-center equipment because the machine must function within a substantially less controlled environment. Successful platforms must accommodate users without professional dialysis training, household electrical and plumbing limitations, variable caregiver availability, storage constraints, remote clinical supervision, and the need for rapid technical support. Consequently, usability engineering has unusually high strategic importance.

The clinical proposition is also different. Traditional in-center hemodialysis is commonly organized around fixed treatment schedules and centralized staffing. Home therapy can provide greater scheduling flexibility and support alternative prescriptions, including more frequent or longer treatments when clinically appropriate. This flexibility creates opportunities to align dialysis more closely with patient lifestyle, work, family responsibilities, travel, and individual fluid-management needs.

Machine adoption nevertheless depends on a complex provider decision. Dialysis organizations must identify appropriate patients, educate them before modality selection, establish vascular-access suitability, conduct home assessments, train patients and caregivers, provide emergency protocols, coordinate supply delivery, establish remote clinical oversight, and maintain contingency arrangements. A technically capable machine therefore does not automatically produce a scalable home program.

For manufacturers, the strategic opportunity lies in reducing friction across this entire pathway. A machine that lowers training burden, simplifies setup, reduces water-management requirements, automatically records treatment information, and improves troubleshooting can generate economic value beyond its hardware price.

This is particularly important because the U.S. dialysis market is heavily influenced by Medicare reimbursement. The ESRD Prospective Payment System bundles dialysis treatment economics around a per-treatment framework, while home and self-dialysis training can receive additional reimbursement under qualifying circumstances. Reimbursement alone, however, does not ensure adoption. Providers require sufficient patient retention and utilization to justify nurse training, home-program staffing, equipment deployment, delivery infrastructure, and technical service.

The period from 2026 to 2035 is therefore expected to shift the commercial discussion from whether home hemodialysis is technically possible to how efficiently home programs can be scaled. Manufacturers able to improve the percentage of trained patients who successfully transition home and remain there are likely to capture disproportionate value.

Key Market Drivers: What’s Fueling the U.S. Home Hemodialysis Machines Market Boom?

The most important underlying driver is the persistent burden of kidney disease. Approximately 37 million U.S. adults are estimated to have chronic kidney disease, with prevalence particularly high among older adults, people with diabetes, and individuals with hypertension. This creates a large upstream population requiring nephrology management and, for a smaller but economically significant group, eventual renal replacement therapy.

Kidney failure remains one of the most resource-intensive chronic conditions in the United States. Patients receiving maintenance dialysis require continuous treatment, creating a durable demand base largely insulated from discretionary healthcare spending cycles. Unlike many elective medical technologies, dialysis cannot generally be deferred indefinitely, which makes the underlying device market clinically resilient.

A second major driver is the low existing penetration of home hemodialysis. Home HHD represents only a small fraction of overall U.S. dialysis utilization. Even modest movement of patients from in-center treatment to home hemodialysis can therefore translate into significant percentage growth for machine placements. This underpenetration provides considerably more headroom than mature in-center dialysis equipment markets.

The third driver is technology simplification. Earlier home hemodialysis systems often required considerable patient training and complicated supply management. The emerging generation of devices increasingly uses guided touchscreens, automated treatment steps, cartridge-based circuits, integrated water technologies, remote data transfer, workflow prompts, and simplified maintenance. These innovations attack one of the market’s core constraints: the difference between clinical capability and practical usability in a residential environment.

Fourth, dialysis providers face capacity and labor economics that increasingly favor alternatives to fixed-center expansion. Building or expanding an outpatient dialysis facility requires real estate, plumbing, water treatment infrastructure, treatment stations, technicians, nurses, regulatory compliance, and recurring overhead. Home dialysis transfers part of the treatment environment away from fixed facilities. Although it creates its own training and logistics costs, a successful program can reduce incremental dependence on dialysis-chair capacity.

Nursing shortages reinforce this dynamic. Dialysis organizations increasingly value machines that allow training staff to teach patients efficiently, standardize workflows, reduce repetitive troubleshooting, and remotely review treatment records. Training duration and patient dropout are therefore becoming commercial metrics comparable in importance to machine acquisition cost.

A fifth driver is the growing influence of value-based kidney care. U.S. nephrology is gradually shifting from isolated treatment reimbursement toward models that reward coordinated management, optimal dialysis starts, transplantation, lower hospitalization, and appropriate modality selection. Even though individual federal payment demonstrations may change over time, the broader strategic direction toward managing the total cost and outcomes of kidney disease remains significant.

Sixth, home therapy can be particularly valuable for geographically dispersed populations. Patients in rural communities may travel long distances multiple times every week to reach dialysis centers. Where broadband access, caregiver support, clinical suitability, and home infrastructure permit, home HHD can reduce transportation burden and give providers a mechanism to serve patients across larger geographic areas.

Seventh, patient preference is becoming more important in modality strategy. Dialysis is not a single episode of care but an ongoing lifestyle commitment. Appropriate patients increasingly expect treatment models that offer greater control over timing and reduce repeated travel to clinics. Manufacturers that design machines around the lived experience of dialysis rather than only around technical specifications are increasingly aligned with this purchasing environment.

Finally, greater competition among machine manufacturers is itself a market catalyst. A category dominated by one widely established portable platform is increasingly becoming a contest among differentiated approaches. Competitive entry encourages provider evaluation, clinical studies, contracting flexibility, software development, service improvements, and continued redesign of home workflows.

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in home hemodialysis is increasingly centered on reducing cognitive and operational complexity. The successful home machine of the next decade will not necessarily be the platform with the greatest number of technical features. It will be the system that safely converts sophisticated dialysis processes into repeatable actions that patients and caregivers can perform consistently.

Guided user interfaces are becoming critical. Modern platforms increasingly use graphical prompts, touchscreen workflows, automated checks, alarms, and step-by-step instructions to reduce dependence on memorization. This has direct economic implications because shorter and more reliable training can expand the pool of patients considered suitable for home therapy while reducing nurse-hours required per transition.

Integrated water management is another important innovation area. Traditional dialysis water requirements create infrastructure challenges for home installation. Systems that integrate purification or generate dialysate on demand can simplify residential deployment, reduce dependence on external water-treatment configurations, and make it easier for providers to standardize installation protocols across heterogeneous homes.

Cartridge-based fluid pathways are also reshaping machine architecture. Disposable cartridges can reduce manual connections and simplify setup, although recurring consumable economics remain important. For providers, the critical metric is not whether a system uses cartridges or conventional circuits but whether the complete workflow reduces error opportunities, training requirements, service events, and treatment interruptions.

Connectivity is becoming a competitive requirement rather than an optional feature. Home dialysis programs must know whether prescribed treatments occurred, whether alarms were generated, how treatment parameters changed, and when clinical intervention may be necessary. Machines that automatically transmit treatment data can reduce manual documentation and support a more scalable remote-care model.

Manufacturers are also developing more flexible platforms capable of serving multiple care environments. A machine that operates across hospital, post-acute, outpatient, transitional, and home settings can create purchasing advantages for integrated health systems because staff training, service infrastructure, and equipment standardization may be shared across sites.

Treatment flexibility is another important area. Home hemodialysis may be prescribed as conventional thrice-weekly treatment, more frequent short sessions, or longer-duration therapy depending on patient circumstances and physician judgment. Machines capable of supporting varied prescriptions without substantially increasing workflow burden provide providers with more freedom to individualize treatment.

Human-factors engineering will remain one of the strongest sources of differentiation. Dialysis machines used by professional nurses can assume a higher level of technical familiarity than devices operated by patients or care partners. Future designs will increasingly emphasize intuitive alarm resolution, error prevention, automated checks, reduced handling steps, clear visual guidance, accessibility, and simplified cleaning.

Remote software is likely to become an increasingly valuable portion of system economics. Machine companies can evolve from capital-equipment suppliers into connected renal-care platform providers through patient portals, clinician dashboards, automatic treatment documentation, predictive service, interoperability, and fleet analytics.

The result is that the U.S. home hemodialysis machine market is moving from device competition toward workflow competition. The winning systems will be those that reduce the total effort required to create and sustain a successful home patient.

Segmentation Insights

The U.S. Home Hemodialysis Machines Market is segmented on the basis of product type, treatment type, end user, technology type, and geography.

By Product Type

Portable and Compact Home Hemodialysis Machines

Portable and compact systems represent the largest product segment and are estimated to account for approximately 46% of the 2025 market. This category has benefited from the established presence of purpose-designed home platforms and provider preference for machines that minimize residential space requirements.

Portability has particular value in home care because dialysis supplies already create a meaningful storage burden. Smaller systems can improve suitability for apartments, smaller households, and patients who want greater mobility. Growth will be supported by next-generation interfaces, easier setup, improved ergonomics, and integration with digital guidance.

Integrated Water-Purification Home Systems

Integrated water-purification systems represent an increasingly important premium category. These machines seek to simplify one of the most complex parts of home dialysis installation by incorporating water treatment and dialysate preparation within the system architecture.

The segment is attractive to providers because reduced infrastructure dependence can broaden the number of homes technically suitable for treatment. It may also lower installation variability and make fleet deployment more standardized. Integrated-water systems are expected to record above-market growth through 2035.

Conventional Home-Configured Hemodialysis Machines

Conventional or legacy machines configured for home use remain relevant for selected programs. They can offer familiar treatment characteristics and may appeal to providers with existing service infrastructure and clinical experience.

However, their relative market share is expected to decline as purchasing decisions increasingly emphasize compact design, easier training, integrated fluid management, remote connectivity, and patient-centered interfaces.

Modular and High-Flow Home Systems

Modular and high-flow systems are emerging as a strategically important category. These platforms seek to combine treatment performance associated with conventional dialysis equipment with interfaces and form factors suitable for self-care.

The segment remains smaller in 2025 but should gain share as newer FDA-cleared systems expand commercialization and providers seek alternatives that allow patients to receive familiar treatment prescriptions across clinic and home environments.

By Treatment Type

Frequent or Short-Daily Home Hemodialysis

Frequent home hemodialysis represents the largest treatment-related revenue opportunity and is estimated to account for roughly 44% of machine-linked market value in 2025. Home treatment removes some of the logistical constraints created by repeated travel to a dialysis center, allowing appropriate patients to receive more frequent prescriptions.

Machine utilization can be high in this segment because equipment is dedicated to an individual household. The commercial value therefore extends beyond installation to service, software, maintenance, and machine-associated accessories.

Conventional Three-Times-Weekly Home Hemodialysis

Conventional thrice-weekly therapy remains an important segment because it allows patients to move treatment location without necessarily changing the familiar cadence of in-center dialysis.

This can reduce the psychological and clinical barrier to home adoption for certain patients. Machines capable of providing conventional treatment performance with simplified residential setup are particularly relevant to this segment.

Nocturnal and Extended-Hour Home Hemodialysis

Nocturnal and extended-duration dialysis represent a smaller but clinically differentiated segment. Longer treatment times can be attractive to selected patients seeking gentler fluid removal or treatment schedules that reduce interference with daytime activity.

The machine requirements are demanding because overnight use places strong emphasis on reliability, alarms, blood-leak safeguards, secure access management, remote oversight, and patient confidence.

Flexible and Hybrid Prescriptions

Flexible prescriptions include patients whose treatment frequency or duration changes according to clinical circumstances, lifestyle, or transition between settings. This segment is expected to expand as dialysis becomes more individualized.

Multi-purpose systems with programmable treatment options and strong data connectivity are likely to benefit because they allow nephrologists to adapt therapy without changing equipment platforms.

By End User

Large Dialysis Provider Home Programs

Large dialysis organizations dominate machine purchasing and placement because they manage extensive ESRD populations, training centers, nephrology relationships, logistics infrastructure, and technical service networks. They are estimated to influence well over half of U.S. home-HHD machine deployments.

These buyers evaluate more than the hardware. Contracting decisions incorporate training time, consumable economics, patient retention, reliability, installation complexity, delivery logistics, clinical support, interoperability, and fleet service.

Integrated Health Systems

Integrated health systems represent a growing end-user category as hospitals seek greater control over kidney-care pathways extending from acute dialysis to outpatient treatment and home management.

Platforms that can function across multiple care environments have a strategic advantage because health systems can standardize equipment, training, data infrastructure, and service relationships. Home HHD may also support hospital strategies aimed at reducing readmissions and improving transitions after kidney failure diagnosis.

Nephrology Practices and Value-Based Kidney Care Organizations

Nephrology groups increasingly influence modality selection as value-based care models give physicians greater economic responsibility for longitudinal kidney outcomes.

These organizations may not directly purchase every machine, but they shape patient education, timing of dialysis initiation, referral pathways, and selection of home therapy. Partnerships between nephrology practices, device manufacturers, and dialysis organizations are therefore becoming commercially important.

Specialized Home Dialysis Providers

Specialized providers focused on home or distributed dialysis represent a smaller but strategically relevant segment. Their operational model makes training efficiency, logistics, remote monitoring, and patient retention especially important.

Such organizations may act as early adopters of technologies that reduce dependence on conventional fixed-center infrastructure.

Patient and Care-Partner Households

Although machines are generally furnished through provider-controlled care pathways rather than conventional consumer purchasing, the household is the true operating environment. Machine success therefore depends heavily on patient and caregiver experience.

Ease of learning, physical footprint, noise, storage needs, alarm management, water requirements, setup time, treatment data transmission, and technical support all influence whether a prescribed home program remains sustainable.

By Technology Type

Cartridge-Based Systems

Cartridge-based platforms are one of the most important technologies in the market because they can reduce manual connections and simplify treatment preparation. Their ability to standardize blood and fluid pathways can be especially valuable in self-care environments.

The recurring economics of proprietary cartridges can strengthen manufacturer revenue but also influence provider contracting. Long-term competitiveness will therefore depend on demonstrating that workflow simplification offsets recurring supply costs.

Integrated Water and On-Demand Dialysate Systems

Integrated water-treatment and on-demand dialysate generation represent a major innovation pathway. These systems seek to reduce dependence on separate water infrastructure or extensive dialysate preparation.

The technology is particularly attractive for provider organizations seeking to expand home programs without creating highly customized residential installations.

Premixed or Batch-Dialysate Systems

Premixed and batch-based approaches remain important because they can enable home treatment without conventional centralized dialysis-water infrastructure. They have established clinical familiarity but may create supply-storage and logistics requirements.

Manufacturers in this category are increasingly optimizing fluid packaging, delivery logistics, and treatment workflows to improve convenience.

Connected and Software-Enabled Home Hemodialysis Systems

Connected machines are expected to be the fastest-growing technology layer through 2035. Automatic treatment documentation, cloud transfer, clinician dashboards, guided setup, fleet management, predictive service, and remote troubleshooting are becoming increasingly important.

Software will not replace dialysis hardware, but it will increasingly determine which hardware platforms scale most efficiently. The highest-value machine ecosystems are likely to combine physical therapy delivery with data infrastructure that reduces operational burden for providers.

Regional Insights: Where the Market is Growing Fastest

The U.S. Home Hemodialysis Machines Market is geographically segmented into the South, West, Northeast, and Midwest. Regional performance differs materially because home HHD adoption is influenced not only by kidney-failure prevalence but also by population growth, diabetes burden, rurality, nephrologist availability, dialysis provider concentration, health-system strategy, housing conditions, transportation burden, payer mix, and willingness to invest in home-program infrastructure.

The South is estimated to be the largest market in 2025 at approximately USD 0.107 billion, representing about 36.9% of national machine revenue. The West accounts for approximately USD 0.070 billion, the Northeast approximately USD 0.064 billion, and the Midwest approximately USD 0.049 billion.

The West is expected to record the fastest regional CAGR through 2035, while the South should retain the largest absolute revenue opportunity.

South

The South represents the largest regional opportunity and includes Delaware, Florida, Georgia, Maryland, North Carolina, South Carolina, Virginia, Washington, D.C., West Virginia, Alabama, Kentucky, Mississippi, Tennessee, Arkansas, Louisiana, Oklahoma, and Texas.

Its market leadership is supported by population scale, rapid demographic growth, substantial diabetes prevalence, high kidney-disease burden in several states, expanding Medicare populations, rural access challenges, and large dialysis-provider networks.

Texas is the most important home hemodialysis machine market in the region. Its combination of more than 30 million residents, major metropolitan areas, extensive nephrology infrastructure, large dialysis organizations, and significant rural geography creates multiple adoption pathways. Houston, Dallas–Fort Worth, San Antonio, and Austin can support sophisticated home programs, while rural Texas creates an economic argument for reducing repeated long-distance trips to dialysis centers.

Florida is another major market because of its large older-adult population and substantial dialysis demand. Home HHD has particular relevance for retirement-oriented communities where treatment flexibility and avoidance of repetitive transportation can materially affect quality of life. Florida also contains large integrated health systems capable of supporting structured home-training and remote-care programs.

Georgia, North Carolina, Tennessee, and Virginia represent important growth states. Large health systems and expanding metropolitan areas are increasing renal-care capacity, while rural communities create persistent access challenges. North Carolina’s research and academic infrastructure makes it relevant for advanced kidney-care pathways, while Tennessee’s large healthcare-services ecosystem increases the state’s strategic importance to provider organizations.

Mississippi, Louisiana, Alabama, Arkansas, Kentucky, and West Virginia have high chronic-disease burdens that create significant long-term dialysis demand. Rural diabetes prevalence has historically been particularly elevated across several of these states. These markets therefore offer strong clinical need but also present some of the greatest operational challenges for home HHD: lower broadband availability in some communities, transportation limitations for training, caregiver constraints, and unequal access to nephrology specialists.

Maryland, Delaware, South Carolina, Oklahoma, and Washington, D.C. represent smaller absolute machine markets but remain relevant through health-system concentration, government healthcare presence, suburban growth, and state-specific kidney-care networks.

By 2035, the South is projected to reach approximately USD 0.388 billion, implying an estimated CAGR of approximately 13.75%. Growth will come from both large metropolitan home programs and technology models designed to extend renal care into underserved communities.

West

The West includes California, Washington, Oregon, Nevada, Arizona, New Mexico, Colorado, Utah, Idaho, Montana, Wyoming, Alaska, and Hawaii. The region is estimated at approximately USD 0.070 billion in 2025 and is expected to grow to approximately USD 0.296 billion by 2035, representing the strongest regional CAGR at approximately 15.51%.

California is the dominant Western state market. Its size, advanced health-system infrastructure, value-based care experimentation, medtech ecosystem, technology-oriented provider networks, and large dialysis population make it a natural launch and evaluation market for connected home-hemodialysis technologies.

The state is particularly attractive for machines combining integrated water management, remote software, simplified patient interfaces, and enterprise interoperability. California health systems and dialysis providers often have sufficient scale to evaluate total cost of care rather than concentrating exclusively on machine acquisition cost.

Washington is strategically important because of the region’s long history in home dialysis and the presence of organizations with substantial experience managing patients outside conventional centers. The state’s home-care orientation provides a commercially useful environment for testing patient education, remote support, and machine-choice models.

Arizona and Nevada are expected to be among the highest-growth markets. Rapid population growth and aging populations support rising ESRD demand. Large retirement communities also create a patient group for whom home treatment flexibility may be particularly valuable.

Colorado and Utah combine population growth with strong integrated health-system infrastructure and comparatively technology-friendly healthcare environments. These states may be attractive for connected HHD platforms because metropolitan populations can be supported centrally while surrounding rural areas create demand for distributed treatment.

Oregon, Idaho, Montana, Wyoming, New Mexico, Alaska, and Hawaii represent smaller markets but illustrate one of home hemodialysis’s strongest geographic arguments. Long travel distances and limited dialysis-center density in selected areas create significant burden for conventional thrice-weekly treatment.

Alaska and Hawaii are particularly distinctive because geographic separation makes transportation and supply logistics unusually important. Home programs can reduce treatment travel, but equipment service, consumable delivery, emergency backup, and installation complexity may be greater.

The West’s faster growth will be driven by technology adoption rather than disease burden alone. Connected care, home-based healthcare, digital workflow integration, and patient-centered delivery models are likely to increase the region’s share of national revenue from approximately 24% in 2025 to almost 28% by 2035.

Northeast

The Northeast includes New York, Pennsylvania, New Jersey, Massachusetts, Connecticut, Rhode Island, Vermont, New Hampshire, and Maine. The region is estimated at approximately USD 0.064 billion in 2025 and is projected to approach USD 0.217 billion by 2035, representing an estimated CAGR of approximately 13.0%.

New York is the largest state opportunity. High population density, substantial ESRD volumes, large academic medical centers, major integrated health systems, and sophisticated nephrology practices support adoption. The market is particularly attractive for technology that can address limited residential space because many patients live in apartments where storage and machine footprint materially affect suitability.

Massachusetts carries disproportionate strategic importance because of its concentration of healthcare innovation, dialysis-industry expertise, medtech companies, academic nephrology programs, and sophisticated purchasing organizations. The state is likely to remain influential in machine evaluation, clinical evidence generation, human-factors research, and renal technology development.

Pennsylvania and New Jersey provide large addressable patient pools and strong provider networks. Pennsylvania combines major metropolitan health systems with substantial rural territory, creating both high-acuity and access-driven use cases for home HHD. New Jersey’s dense healthcare infrastructure and proximity to major dialysis and life-science organizations support adoption of premium platforms.

Connecticut, Rhode Island, New Hampshire, Vermont, and Maine represent smaller absolute markets. Their importance lies in mature healthcare systems and the potential for home therapy to support aging and geographically dispersed populations.

The Northeast is unlikely to match the West’s growth rate because dialysis infrastructure is mature and population growth is slower. However, it should remain one of the highest-value markets on a per-patient basis because health systems often place significant emphasis on evidence, patient experience, safety, and technology integration.

Procurement in the Northeast is likely to remain clinically rigorous. Manufacturers seeking share must demonstrate not only that machines deliver adequate dialysis but also that they can improve successful home conversion, training efficiency, retention, remote oversight, and program economics.

Midwest

The Midwest includes Illinois, Indiana, Michigan, Ohio, Wisconsin, Minnesota, Iowa, Missouri, Kansas, Nebraska, North Dakota, and South Dakota. The regional market is estimated at approximately USD 0.049 billion in 2025 and is projected to reach approximately USD 0.159 billion by 2035, representing an estimated CAGR of approximately 12.49%.

Illinois, Ohio, Michigan, and Minnesota are the most commercially significant markets. Chicago anchors a large academic and community dialysis ecosystem, while Ohio has major health systems and nephrology networks capable of supporting sophisticated home programs.

Michigan has a substantial chronic-disease burden and a large established dialysis infrastructure. Home HHD expansion will depend on provider education, modality selection, and the ability to support patients across both metropolitan and rural areas.

Minnesota is strategically relevant because of its medtech heritage and concentration of healthcare expertise. Integrated delivery systems in the state can evaluate home machines using broader care-pathway economics rather than isolated equipment price.

Wisconsin, Indiana, Missouri, Iowa, and Kansas offer stable demand and meaningful rural home-dialysis opportunities. In these states, travel time to treatment facilities can create a strong patient-level rationale for home therapy, especially when reliable remote support is available.

Nebraska, North Dakota, and South Dakota are smaller machine markets but illustrate the value of distributed renal-care technology. Low population density can make conventional dialysis facility economics challenging outside major cities. Home treatment can therefore become strategically important for maintaining access, although technical service and logistics must be designed for large geographic territories.

The Midwest is expected to lose modest national market share as faster-growing Southern and Western states capture a larger portion of patient and technology investment. Nevertheless, the region should remain a durable market characterized by stable renal-care demand, major integrated delivery networks, and meaningful rural access requirements.

Key Market Players

The U.S. Home Hemodialysis Machines Competitive Landscape is considerably more concentrated at the machine-manufacturer level than the broader dialysis equipment market. Fresenius Medical Care/NxStage has the deepest dedicated U.S. home-HHD installed base, while Outset Medical and Quanta Dialysis Technologies have introduced differentiated architectures that increase competitive choice.

The broader ecosystem also includes dialysis providers, renal technology manufacturers, dialysate and component suppliers, value-based kidney-care organizations, and specialist home-care operators. These organizations can materially influence equipment selection, patient referral, home-program design, clinical education, machine utilization, and commercialization.

Some of the key manufacturers, providers, and strategic ecosystem participants relevant to the U.S. market include:

Fresenius Medical Care / NxStage Medical
Outset Medical
Quanta Dialysis Technologies
Baxter International
B. Braun Medical
Nipro Medical Corporation
Asahi Kasei Medical
Toray Medical
Mozarc Medical
Diality
DaVita
U.S. Renal Care
Satellite Healthcare
Northwest Kidney Centers
Innovative Renal Care
Dialyze Direct
Concerto Renal Services
Somatus
Interwell Health
Strive Health
Monogram Health
Panoramic Health
Evergreen Nephrology
Rockwell Medical

Competitive positioning differs substantially across these organizations. Fresenius combines device manufacturing, NxStage technology, dialysis services, home-patient infrastructure, clinical education, and supply-chain scale. Its U.S. NxStage home population surpassed 15,000 patients in 2025, creating an installed-base advantage that new competitors must address through differentiation rather than simple product parity.

Outset Medical approaches the market through a machine designed to operate across the dialysis continuum. Its integrated water purification, on-demand dialysate, touchscreen interface, and connected architecture are intended to reduce fixed infrastructure and workflow complexity. The commercial challenge is converting the company’s broader hospital and post-acute installed base into sustained home-HHD adoption.

Quanta represents one of the most strategically important emerging competitors. Its home clearance adds a high-flow alternative capable of serving multiple dialysis environments. Successful expansion would increase customer choice and could accelerate provider re-evaluation of home-HHD machine portfolios.

Competition through 2035 will increasingly be determined by measurable program economics. Manufacturers must demonstrate low training burden, high home-conversion rates, patient retention, reliable field service, manageable consumable logistics, treatment flexibility, remote data visibility, and acceptable lifetime cost.

The market is therefore unlikely to become a commodity equipment category. Switching costs are meaningful because machine choice affects nurse training, patient education, disposables, logistics, clinical protocols, technical service, and remote data systems.

Recent Developments

The U.S. home hemodialysis machine market has experienced a meaningful increase in competitive activity since 2024.

One of the most important developments was the expansion of Fresenius Medical Care’s NxStage platform through the introduction of VersiHD with GuideMe software. The platform emphasizes graphical treatment guidance and simplified user interaction. U.S. utilization has continued to increase, with more than 15,300 patients reported using NxStage systems for home hemodialysis in 2025.

Regulatory development has continued into 2026, including additional FDA clearance activity around the NxStage System One platform. This reinforces the continuing product-development cycle in a category that historically experienced relatively limited competitive turnover.

Quanta Dialysis Technologies received U.S. clearance for home use of its dialysis system in November 2024. This was strategically important because it created another differentiated platform for home HHD and expanded Quanta’s potential reach from acute and sub-acute care into residential treatment.

Quanta’s completed home clinical program evaluated patients transitioning from in-clinic training to self-care treatment at home. The commercial significance extends beyond regulatory clearance: providers now have an additional machine architecture to consider when building home programs.

Outset Medical continues to position Tablo as a platform extending from hospital to home. The company generated approximately USD 119.5 million in total revenue during 2025 across its broader business and reported an expanding base of healthcare sites using Tablo. For the home segment specifically, the strategic opportunity is to use an installed enterprise footprint to facilitate patient transitions from inpatient or outpatient treatment into residential dialysis.

Provider partnerships are also becoming more important. Home-dialysis organizations are evaluating multiple machines rather than treating equipment selection as fixed indefinitely. Northwest Kidney Centers, for example, announced an initiative in 2025 to add Tablo to its home-hemodialysis options. This is representative of a broader trend toward patient-choice and multi-platform home programs.

Reimbursement policy has also evolved. Beginning in 2025, Medicare expanded payment availability for home dialysis services furnished to qualifying beneficiaries with acute kidney injury. Although chronic ESRD remains the principal commercial population for home machines, the policy broadens the conceptual scope of home renal replacement therapy and may create additional utilization pathways.

At the same time, manufacturers cannot assume that policy will continuously move in one direction. The federal ESRD Treatment Choices Model was terminated earlier than its original schedule after evaluation results did not demonstrate the anticipated level of savings and quality improvement. This reinforces an important market principle: long-term HHD growth must ultimately be supported by sustainable provider economics and patient outcomes rather than temporary payment incentives.

The next competitive cycle will therefore focus on practical execution. Home-machine manufacturers will be judged on how many eligible patients can be trained, how quickly training can be completed, how many patients successfully transition home, how long they remain on therapy, how frequently technical interventions are required, and whether the program improves the total economics of renal care.

Conclusion

The U.S. Home Hemodialysis Machines Market Size & Share is positioned for high-growth expansion from approximately USD 0.29 billion in 2025 to USD 1.06 billion by 2035, representing a projected CAGR of 13.84% during 2026–2035.

Historical market value increased from approximately USD 0.18 billion in 2021 to USD 0.20 billion in 2022, USD 0.23 billion in 2023, USD 0.26 billion in 2024, and USD 0.29 billion in 2025. This acceleration reflects increasing acceptance of home renal replacement therapy, continued growth of the installed home-HHD population, machine simplification, connected-care capabilities, and entry of differentiated competitors.

The primary market opportunity is not simply replacement of existing home machines. It is expansion of the number of U.S. dialysis patients who can realistically initiate and remain on home hemodialysis.

That distinction materially changes how the market should be assessed. Hardware specifications remain important, but future winners will be determined by successful home conversion, training efficiency, patient retention, system reliability, logistics, remote oversight, and total program economics.

Portable and compact machines currently form the largest product category, while integrated water-management and connected platforms are expected to capture increasing value. Frequent and short-daily therapy remains central to home-HHD utilization, although conventional thrice-weekly home dialysis could expand as newer systems make migration from in-center treatment operationally easier.

Large dialysis organizations remain the most influential buyers, but integrated health systems, nephrology groups, value-based kidney-care organizations, and specialized home providers will gain importance as treatment decisions become more longitudinal.

Geographically, the South is expected to remain the largest U.S. market, supported by its population scale, diabetes burden, aging demographics, dialysis prevalence, and rural access needs. The West should be the fastest-growing region, driven by connected-care adoption, innovation-oriented health systems, population growth, and greater willingness to deploy new home-treatment platforms. The Northeast will remain a premium evidence-driven market, while the Midwest will provide durable demand supported by large health systems and rural access requirements.

Fresenius Medical Care/NxStage enters the forecast period with the strongest established U.S. home-HHD position, but Outset Medical and Quanta Dialysis Technologies are increasing credible machine competition. Additional innovation in water management, human-factors engineering, software, cartridges, remote monitoring, and treatment flexibility should further change the market structure through 2035.

For manufacturers, providers, investors, and strategic buyers evaluating this market, the central question is therefore not whether the burden of kidney failure will sustain dialysis demand. It will.

The more consequential questions are how rapidly patients can be migrated from conventional centers to sustainable home programs, which machine platforms can remove the largest operational barriers, and which companies can convert technical innovation into measurable clinical and economic value.

The strongest long-term opportunity belongs to organizations that treat the home hemodialysis machine not as a stand-alone piece of capital equipment, but as the operating center of a connected, patient-managed renal-care ecosystem.

TABLE OF CONTENTS

1. U.S. Home Hemodialysis Machines Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Market Sizing, Analytical Frameworks & Forecasting Models
1.3.6. Data Triangulation, Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Revenue Boundary and Inclusion/Exclusion Framework
1.5.1. Home Hemodialysis Machine Revenue
1.5.2. Machine-Integrated Accessories and Hardware
1.5.3. Machine-Linked Software and Connectivity Revenue
1.5.4. Service, Maintenance and Upgrade Revenue
1.5.5. Exclusion of Routine Dialyzers, Bloodlines, Drugs and General Treatment Consumables
1.6. U.S. Home Hemodialysis Market Ecosystem Overview
1.7. Stakeholder Analysis
1.7.1. Home Hemodialysis Machine Manufacturers
1.7.2. Dialysis Equipment Component and Contract Manufacturing Suppliers
1.7.3. Large Dialysis Organizations
1.7.4. Integrated Health Systems and Hospital Networks
1.7.5. Nephrology Practices and Kidney Care Organizations
1.7.6. Specialized Home Dialysis Providers
1.7.7. Home Dialysis Nurses and Clinical Educators
1.7.8. Patients and Care Partners
1.7.9. Distributors, Logistics and Technical Service Providers
1.7.10. CMS, Commercial Payers, Regulators and Clinical Decision-Makers

What this section provides: Establishes the precise U.S. home hemodialysis machine market boundary, revenue inclusions and exclusions, methodology, forecasting assumptions, and stakeholder ecosystem used throughout the report.

2. U.S. Home Hemodialysis Machines Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. U.S. Home Hemodialysis Installed-Base Evolution
2.8. Home Hemodialysis Penetration Versus In-Center Hemodialysis
2.9. Leading Product and Technology Opportunity Areas
2.10. Regional Growth Hotspots
2.11. Competitive Intensity and Market Concentration
2.12. High-Growth Commercial Opportunity Areas

What this section provides: Gives executives a concise view of the 2025 market position, historical trajectory, 2026–2035 growth outlook, adoption potential, major technology opportunities, regional demand pockets, and competitive priorities.

3. U.S. Home Hemodialysis Machines Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. High U.S. Chronic Kidney Disease and Kidney Failure Burden
3.1.2. Low Current Penetration of Home Hemodialysis
3.1.3. Increasing Patient Preference for Home-Based Renal Replacement Therapy
3.1.4. Expansion of Value-Based Kidney Care Models
3.1.5. Dialysis Facility Capacity and Nursing Workforce Constraints
3.1.6. Growth in Compact and Patient-Friendly Hemodialysis Machines
3.1.7. Increasing Remote Monitoring and Connected Home Dialysis Adoption
3.1.8. Rural Dialysis Access and Transportation Burden
3.1.9. Greater Provider Focus on Home Modality Education
3.2. Restraints and Their Impact Analysis
3.2.1. Patient Training Complexity and Long Training Cycles
3.2.2. Vascular Access and Self-Cannulation Challenges
3.2.3. Caregiver Availability and Patient Eligibility Constraints
3.2.4. Residential Space, Electrical, Plumbing and Water Requirements
3.2.5. High Home Program Setup and Support Costs
3.2.6. Patient Dropout and Modality Retention Challenges
3.2.7. Emergency Backup and Technical Support Requirements
3.3. Opportunities and Their Impact Analysis
3.3.1. Conversion of In-Center Hemodialysis Patients to Home Therapy
3.3.2. Home Hemodialysis Adoption Among Incident Dialysis Patients
3.3.3. Integrated Water-Purification Systems
3.3.4. Cartridge-Based and Simplified Disposable Architectures
3.3.5. Connected Machines and Automated Treatment Documentation
3.3.6. Remote Clinical Oversight and Predictive Service
3.3.7. Home Dialysis Expansion Across Rural and Underserved Communities
3.3.8. Multi-Setting Machines Supporting Hospital-to-Home Transitions
3.3.9. Home Hemodialysis for Eligible Acute Kidney Injury Patients
3.4. Challenges and Their Impact Analysis
3.4.1. Patient Selection and Home Suitability Assessment
3.4.2. Training Nurse Availability
3.4.3. Consumable Delivery and Residential Storage
3.4.4. Technical Service Coverage Across Distributed Home Fleets
3.4.5. Achieving Sustainable Home Patient Retention
3.5. Patent & Innovation Analysis, 2021–2025
3.6. Home Dialysis Clinical Workflow Economics Analysis
3.7. Provider Capital Procurement and Machine Placement Behavior
3.8. Home Versus In-Center Dialysis Economic Comparison
3.9. Home Hemodialysis Patient Conversion Funnel Analysis
3.10. Home Hemodialysis Training and Retention Economics

What this section provides: Assesses the clinical, reimbursement, operational and economic factors determining home HHD adoption and quantifies where machine manufacturers and dialysis providers can capture sustainable growth.

4. U.S. Home Hemodialysis Machines Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Dialysis Providers and Health Systems
4.2.3. Bargaining Power of Component and Consumable Suppliers
4.2.4. Substitution Risk from In-Center Hemodialysis, Peritoneal Dialysis and Transplantation
4.2.5. Competitive Rivalry
4.3. Home Hemodialysis Machine Pricing Trend Analysis, 2025–2035
4.4. Value Chain & Supply Chain Analysis
4.5. Dialysis Machine Component Supply Analysis
4.6. Water Treatment and Dialysate Supply Ecosystem
4.7. Impact of Digitalization and Connected Home Kidney Care
4.8. Human-Factors Engineering and Patient Usability Landscape
4.9. FDA Regulatory Framework for Home Hemodialysis Machines
4.10. CMS ESRD Prospective Payment System Analysis
4.11. Home and Self-Dialysis Training Reimbursement Landscape
4.12. Medicare Coverage and Home Dialysis Payment Dynamics
4.13. Commercial Payer and Medicare Advantage Considerations
4.14. Import/Export Restrictions & Tariff Impact
4.15. Federal Kidney Care Initiatives and Policy Landscape
4.16. Impact of Escalating Geopolitical and Supply-Chain Tensions
4.17. Cybersecurity and Connected Medical Device Requirements
4.18. Dialysis Provider Value Analysis and Machine Selection Framework

What this section provides: Gives clients an integrated view of U.S. regulation, reimbursement, pricing, supply chain, connected-device requirements, competitive economics, and procurement criteria affecting home hemodialysis machine commercialization.

5. U.S. Home Hemodialysis Machines Market – By Product Type

5.1. Overview
5.1.1. Segment Share Analysis, By Product Type, 2025 & 2035 (%)
5.1.2. Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
5.1.3. Portable & Compact Home Hemodialysis Machines
5.1.4. Integrated Water-Purification Home Hemodialysis Systems
5.1.5. Conventional Home-Configured Hemodialysis Machines
5.1.6. Modular and High-Flow Home Hemodialysis Systems

What this section provides: Identifies the machine configurations expected to contribute the greatest revenue and evaluates the shift toward compact, integrated-water and high-performance home platforms through 2035.

6. U.S. Home Hemodialysis Machines Market – By Treatment Regimen

6.1. Overview
6.1.1. Segment Share Analysis, By Treatment Regimen, 2025 & 2035 (%)
6.1.2. Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
6.1.3. Frequent / Short-Daily Home Hemodialysis
6.1.4. Conventional Three-Times-Weekly Home Hemodialysis
6.1.5. Nocturnal Home Hemodialysis
6.1.6. Extended-Hour Home Hemodialysis
6.1.7. Flexible and Hybrid Home Hemodialysis Prescriptions

What this section provides: Evaluates machine demand according to treatment frequency and duration, showing how evolving prescriptions influence machine utilization, performance requirements and revenue opportunities.

7. U.S. Home Hemodialysis Machines Market – By End User

7.1. Overview
7.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
7.1.2. Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
7.1.3. Large Dialysis Provider Home Programs
7.1.4. Integrated Health Systems and Hospital Networks
7.1.5. Nephrology Practices and Value-Based Kidney Care Organizations
7.1.6. Specialized Home Dialysis Providers
7.1.7. Independent and Regional Dialysis Organizations
7.1.8. Patient and Care-Partner Households

What this section provides: Defines the customer and user groups influencing machine deployment and highlights differences in purchasing behavior, training infrastructure, patient management and home-program economics.

8. U.S. Home Hemodialysis Machines Market – By Technology Type

8.1. Overview
8.1.1. Segment Share Analysis, By Technology Type, 2025 & 2035 (%)
8.1.2. Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
8.1.3. Cartridge-Based Hemodialysis Systems
8.1.4. Integrated Water and On-Demand Dialysate Systems
8.1.5. Premixed and Batch-Dialysate Systems
8.1.6. High-Flow Conventional-Dialysate Home Systems
8.1.7. Connected and Software-Enabled Home Hemodialysis Systems
8.1.8. Automated Patient-Guidance and Treatment Workflow Technologies

What this section provides: Examines the technologies transforming home dialysis usability, water management, dialysate preparation, remote oversight, automation and treatment flexibility.

9. U.S. Home Hemodialysis Machines Market – By Procurement & Deployment Model

9.1. Overview
9.1.1. Segment Share Analysis, By Procurement & Deployment Model, 2025 & 2035 (%)
9.1.2. Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)
9.1.3. Provider-Owned Capital Purchase
9.1.4. Machine Leasing and Rental Models
9.1.5. Per-Treatment and Consumables-Linked Machine Placement
9.1.6. Enterprise Dialysis Organization and Health-System Contracts
9.1.7. Manufacturer-Managed Home Deployment and Service Models
9.1.8. Specialty Distributor and Technical Service Partner Channels

What this section provides: Shows how home HHD equipment is acquired, financed, placed and serviced, enabling clients to assess contracting models, customer economics, recurring revenue potential and commercial channel strategy.

10. U.S. Home Hemodialysis Machines Market – By Geography
10.1. Introduction

10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Home Hemodialysis Patient and Installed-Base Analysis
10.1.4. Regional Kidney Failure and Dialysis Demand Analysis
10.1.5. Regional Home Dialysis Penetration Analysis
10.1.6. Regional Nephrologist, Training and Provider Infrastructure Analysis
10.1.7. Rural Access and Dialysis Transportation Burden Analysis
10.1.8. Regional Reimbursement and Procurement Dynamics

10.2. West Region

10.2.1. Regional Overview & Trends
10.2.2. West Region Home Hemodialysis Key Manufacturers, Providers and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.2.9. California

10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.2.10. Washington

10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.2.11. Arizona

10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.2.12. Colorado

10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.2.13. Oregon

10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.2.14. Utah

10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.2.15. Nevada

10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.2.16. New Mexico

10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.2.17. Idaho

10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.2.18. Montana

10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.2.19. Wyoming

10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.2.20. Alaska

10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.2.21. Hawaii

10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.3. Northeast Region

10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Home Hemodialysis Key Manufacturers, Providers and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.3.9. New York

10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.3.10. Massachusetts

10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.3.11. New Jersey

10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.3.12. Pennsylvania

10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.3.13. Connecticut

10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.3.14. Maine

10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.3.15. Vermont

10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.3.16. New Hampshire

10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.3.17. Rhode Island

10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.4. South Region

10.4.1. Regional Overview & Trends
10.4.2. South Region Home Hemodialysis Key Manufacturers, Providers and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.4.9. Texas

10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.4.10. Florida

10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.4.11. Georgia

10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.4.12. North Carolina

10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.4.13. Tennessee

10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.4.14. South Carolina

10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.4.15. Alabama

10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.4.16. Mississippi

10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.4.17. Louisiana

10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.4.18. Arkansas

10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.4.19. Kentucky

10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.4.20. Oklahoma

10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.4.21. Virginia

10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.4.22. Maryland

10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.4.23. West Virginia

10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.4.24. Delaware

10.4.24.1. Overview
10.4.24.2. Delaware Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.24.3. Delaware Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.4.24.4. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.24.5. Delaware Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.24.6. Delaware Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.4.25. District of Columbia – Supplemental Federal District Analysis

10.4.25.1. Overview
10.4.25.2. District of Columbia Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.25.3. District of Columbia Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.4.25.4. District of Columbia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.25.5. District of Columbia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.25.6. District of Columbia Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.5. Midwest Region

10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Home Hemodialysis Key Manufacturers, Providers and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.5.9. Illinois

10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.5.10. Ohio

10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.5.11. Michigan

10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.5.12. Minnesota

10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.5.13. Indiana

10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.5.14. Wisconsin

10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.5.15. Missouri

10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.5.16. Iowa

10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.5.17. Kansas

10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.5.18. Nebraska

10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.5.19. North Dakota

10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

10.5.20. South Dakota

10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Treatment Regimen, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By Procurement & Deployment Model, 2021–2035 (US$ Billion)

What this section provides: Delivers detailed regional and state-level intelligence across all 50 U.S. states, plus supplemental District of Columbia coverage, allowing clients to identify home-HHD adoption hotspots, underserved territories, provider concentrations, installed-base opportunities and state-level commercial priorities.

11. U.S. Home Hemodialysis Machines Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.2. Competitive Concentration Analysis
11.3. Home Hemodialysis Installed-Base Benchmarking
11.4. Competitive Positioning Matrix
11.4.1. Market Leaders
11.4.2. Challengers
11.4.3. Technology Innovators
11.4.4. Emerging Players
11.5. Product Portfolio Benchmarking
11.6. Machine Usability and Training-Time Benchmarking
11.7. Water Management Technology Benchmarking
11.8. Connectivity and Remote Monitoring Benchmarking
11.9. Service and Technical Support Benchmarking
11.10. Strategic Partnerships, Distribution and Provider Relationships
11.11. Company Profiles

11.11.1. Fresenius Medical Care / NxStage Medical
11.11.2. Outset Medical, Inc.
11.11.3. Quanta Dialysis Technologies
11.11.4. Baxter International Inc.
11.11.5. B. Braun Medical Inc.
11.11.6. Nipro Medical Corporation
11.11.7. Asahi Kasei Medical Co., Ltd.
11.11.8. Toray Medical Co., Ltd.
11.11.9. Mozarc Medical
11.11.10. Diality Inc.
11.11.11. DaVita Inc.
11.11.12. U.S. Renal Care
11.11.13. Satellite Healthcare
11.11.14. Northwest Kidney Centers
11.11.15. Innovative Renal Care
11.11.16. Dialyze Direct
11.11.17. Concerto Renal Services
11.11.18. Dialysis Clinic, Inc.
11.11.19. Somatus, Inc.
11.11.20. Interwell Health
11.11.21. Strive Health
11.11.22. Monogram Health
11.11.23. Panoramic Health
11.11.24. Evergreen Nephrology
11.11.25. Rockwell Medical, Inc.

Note: Each applicable company profile will cover company overview, U.S. renal-care presence, home hemodialysis relevance, machine or service portfolio, technology positioning, commercial strategy, partnerships, regulatory developments, financial positioning, competitive strengths and recent developments.

What this section provides: Gives clients machine-manufacturer and kidney-care ecosystem benchmarking, competitive positioning, installed-base visibility, technology differentiation, provider relationships and strategic intelligence on the organizations shaping U.S. home hemodialysis adoption.

12. U.S. Home Hemodialysis Machines Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Adoption Scenario
12.1.2. Realistic Adoption Scenario
12.1.3. Pessimistic Adoption Scenario
12.2. Home Hemodialysis Penetration Scenarios
12.3. Disruptive Technologies Impact
12.3.1. Simplified Cartridge-Based Dialysis
12.3.2. Integrated Water Purification
12.3.3. On-Demand Dialysate Generation
12.3.4. High-Flow Home Dialysis Platforms
12.3.5. Automated Patient-Guidance Technologies
12.3.6. Remote Treatment Monitoring
12.3.7. Predictive Machine Maintenance
12.3.8. AI-Assisted Home Dialysis Workflow Management
12.3.9. Connected Kidney Care Platforms
12.4. Emerging Business Trends
12.4.1. Multi-Platform Home Dialysis Programs
12.4.2. Hospital-to-Home Dialysis Transition Models
12.4.3. Value-Based Kidney Care Integration
12.4.4. Remote Home Dialysis Nursing Models
12.4.5. Patient Choice and Shared Decision-Making
12.5. Business Opportunities for Startups and Existing Players
12.6. Investment Prioritization Matrix
12.7. Technology Adoption Curve, 2026–2035
12.8. Market White-Space Analysis

What this section provides: Prepares clients for changes in technology, home-HHD penetration, competitive structure and care delivery while identifying the innovation themes and business models most likely to create value through 2035.

13. U.S. Home Hemodialysis Machines Market: Strategic Recommendations

13.1. Recommendations for Home Hemodialysis Machine Manufacturers
13.2. Recommendations for Dialysis Organizations
13.3. Recommendations for Hospitals and Integrated Health Systems
13.4. Recommendations for Nephrology Practices
13.5. Recommendations for Value-Based Kidney Care Organizations
13.6. Recommendations for Investors and Private Equity Firms
13.7. Recommendations for Distributors and Technical Service Partners
13.8. Recommendations for New Entrants and Startups
13.9. Go-to-Market Strategy Considerations
13.10. Patient Training and Retention Strategy
13.11. Home Program Scaling Strategy
13.12. Product Positioning and Portfolio Expansion Guidance
13.13. Regional Market Entry Prioritization
13.14. Partnership and Provider Contracting Strategy
13.15. Pricing and Commercial Model Recommendations

What this section provides: Converts market intelligence into actionable recommendations for market entry, product development, home-program scaling, contracting, investment, regional expansion and competitive differentiation.

14. U.S. Home Hemodialysis Machines Market: Disclaimer

14.1. Scope Limitation
14.2. Market Definition and Revenue Boundary Limitation
14.3. Data Use Limitation
14.4. Historical Data Limitation
14.5. Forecasting Limitation
14.6. State-Level Estimation Limitation
14.7. Legal Disclaimer
14.8. Third-Party Data Disclaimer

What this section provides: Defines the report’s analytical boundaries, market-sizing limitations, forecast assumptions, state-level estimation considerations, legal terms and appropriate use of the research findings.

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Home Hemodialysis Machines Market: Market Definition and Scope
TABLE 3: U.S. Home Hemodialysis Machines Market: Research Methodology Framework
TABLE 4: U.S. Home Hemodialysis Machines Market: Key Assumptions
TABLE 5: U.S. Home Hemodialysis Machines Market: Revenue Boundary and Inclusion/Exclusion Framework
TABLE 6: U.S. Home Hemodialysis Machines Market: Market Ecosystem and Stakeholder Analysis
TABLE 7: U.S. Home Hemodialysis Machines Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. Home Hemodialysis Machines Market: Analyst Viewpoint Summary
TABLE 9: U.S. Home Hemodialysis Machines Market: Market Attractiveness Index
TABLE 10: U.S. Home Hemodialysis Machines Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Home Hemodialysis Machines Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 12: U.S. Home Hemodialysis Machines Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 13: U.S. Home Hemodialysis Machines Market: Home HHD Installed Base and Penetration Snapshot
TABLE 14: U.S. Home Hemodialysis Machines Market: Drivers; Impact Analysis
TABLE 15: U.S. Home Hemodialysis Machines Market: Restraints; Impact Analysis
TABLE 16: U.S. Home Hemodialysis Machines Market: Opportunities; Impact Analysis
TABLE 17: U.S. Home Hemodialysis Machines Market: Challenges; Impact Analysis
TABLE 18: U.S. Home Hemodialysis Machines Market: Patent & Innovation Analysis, 2021–2025
TABLE 19: U.S. Home Hemodialysis Machines Market: Home Dialysis Clinical Workflow Economics Matrix
TABLE 20: U.S. Home Hemodialysis Machines Market: Provider Capital Procurement and Machine Placement Matrix
TABLE 21: U.S. Home Hemodialysis Machines Market: Home Versus In-Center Hemodialysis Economics
TABLE 22: U.S. Home Hemodialysis Machines Market: Patient Conversion Funnel Analysis
TABLE 23: U.S. Home Hemodialysis Machines Market: Training and Patient Retention Economics
TABLE 24: U.S. Home Hemodialysis Machines Market: PESTEL Analysis
TABLE 25: U.S. Home Hemodialysis Machines Market: Porter’s Five Forces Analysis
TABLE 26: U.S. Home Hemodialysis Machines Market: Machine Pricing Trend Analysis, 2025–2035
TABLE 27: U.S. Home Hemodialysis Machines Market: Value Chain Analysis
TABLE 28: U.S. Home Hemodialysis Machines Market: Supply Chain Analysis
TABLE 29: U.S. Home Hemodialysis Machines Market: Dialysis Machine Component Supply Analysis
TABLE 30: U.S. Home Hemodialysis Machines Market: Water Treatment and Dialysate Ecosystem
TABLE 31: U.S. Home Hemodialysis Machines Market: Digitalization and Connected Home Dialysis Impact
TABLE 32: U.S. Home Hemodialysis Machines Market: FDA Regulatory Framework Analysis
TABLE 33: U.S. Home Hemodialysis Machines Market: CMS ESRD PPS and Home Dialysis Reimbursement Landscape
TABLE 34: U.S. Home Hemodialysis Machines Market: Medicare and Commercial Payer Dynamics
TABLE 35: U.S. Home Hemodialysis Machines Market: Supply Chain, Tariff and Geopolitical Impact
TABLE 36: U.S. Home Hemodialysis Machines Market: Product Type Snapshot, 2025
TABLE 37: Segment Dashboard; Definition and Scope, by Product Type
TABLE 38: U.S. Home Hemodialysis Machines Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 39: U.S. Home Hemodialysis Machines Market: Segment Share Analysis, by Product Type, 2025 & 2035 (%)
TABLE 40: Portable & Compact Home Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 41: Integrated Water-Purification Home Hemodialysis Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 42: Conventional Home-Configured Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 43: Modular and High-Flow Home Hemodialysis Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 44: U.S. Home Hemodialysis Machines Market: Treatment Regimen Snapshot, 2025
TABLE 45: Segment Dashboard; Definition and Scope, by Treatment Regimen
TABLE 46: U.S. Home Hemodialysis Machines Market, by Treatment Regimen, 2021–2035 (US$ Billion)
TABLE 47: U.S. Home Hemodialysis Machines Market: Segment Share Analysis, by Treatment Regimen, 2025 & 2035 (%)
TABLE 48: Frequent / Short-Daily Home Hemodialysis Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 49: Conventional Three-Times-Weekly Home Hemodialysis Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 50: Nocturnal Home Hemodialysis Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 51: Extended-Hour Home Hemodialysis Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 52: Flexible and Hybrid Home Hemodialysis Prescriptions Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 53: U.S. Home Hemodialysis Machines Market: End User Snapshot, 2025
TABLE 54: Segment Dashboard; Definition and Scope, by End User
TABLE 55: U.S. Home Hemodialysis Machines Market, by End User, 2021–2035 (US$ Billion)
TABLE 56: U.S. Home Hemodialysis Machines Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 57: Large Dialysis Provider Home Programs Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 58: Integrated Health Systems and Hospital Networks Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 59: Nephrology Practices and Value-Based Kidney Care Organizations Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 60: Specialized and Independent Home Dialysis Providers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 61: Patient and Care-Partner Households Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 62: U.S. Home Hemodialysis Machines Market: Technology Type Snapshot, 2025
TABLE 63: Segment Dashboard; Definition and Scope, by Technology Type
TABLE 64: U.S. Home Hemodialysis Machines Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 65: U.S. Home Hemodialysis Machines Market: Segment Share Analysis, by Technology Type, 2025 & 2035 (%)
TABLE 66: Cartridge-Based Hemodialysis Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 67: Integrated Water and On-Demand Dialysate Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 68: Premixed and Batch-Dialysate Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 69: High-Flow Conventional-Dialysate Home Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 70: Connected and Software-Enabled Home Hemodialysis Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 71: U.S. Home Hemodialysis Machines Market: Procurement & Deployment Model Snapshot, 2025
TABLE 72: Segment Dashboard; Definition and Scope, by Procurement & Deployment Model
TABLE 73: U.S. Home Hemodialysis Machines Market, by Procurement & Deployment Model, 2021–2035 (US$ Billion)
TABLE 74: U.S. Home Hemodialysis Machines Market: Segment Share Analysis, by Procurement & Deployment Model, 2025 & 2035 (%)
TABLE 75: Provider-Owned Capital Purchase Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 76: Machine Leasing and Rental Models Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 77: Per-Treatment and Consumables-Linked Machine Placement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 78: Enterprise Dialysis Organization and Health-System Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 79: Manufacturer-Managed Deployment and Specialty Service Models Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 80: U.S. Home Hemodialysis Machines Market: Regional Snapshot, 2025
TABLE 81: Segment Dashboard; Definition and Scope, by Geography
TABLE 82: U.S. Home Hemodialysis Machines Market, by Region, 2021–2035 (US$ Billion)
TABLE 83: U.S. Home Hemodialysis Machines Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 84: U.S. Home Hemodialysis Machines Market: Regional Home HHD Penetration and Installed-Base Analysis
TABLE 85: West Region U.S. Home Hemodialysis Machines Market: Regional Overview and Trends
TABLE 86: West Region U.S. Home Hemodialysis Machines Market, by State, 2021–2035 (US$ Billion)
TABLE 87: West Region U.S. Home Hemodialysis Machines Market, by Product Type and Technology Type, 2021–2035 (US$ Billion)
TABLE 88: California Home Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 89: Washington Home Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 90: Arizona Home Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 91: Colorado Home Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 92: Oregon Home Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 93: Utah Home Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 94: Nevada Home Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 95: New Mexico Home Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 96: Idaho Home Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 97: Montana Home Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 98: Wyoming Home Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 99: Alaska Home Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 100: Hawaii Home Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 101: Northeast Region U.S. Home Hemodialysis Machines Market: Regional Overview and Trends
TABLE 102: Northeast Region U.S. Home Hemodialysis Machines Market, by State, 2021–2035 (US$ Billion)
TABLE 103: Northeast Region U.S. Home Hemodialysis Machines Market, by Product Type and Technology Type, 2021–2035 (US$ Billion)
TABLE 104: New York Home Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 105: Massachusetts Home Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 106: New Jersey Home Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 107: Pennsylvania Home Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 108: Connecticut Home Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 109: Maine Home Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 110: Vermont Home Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 111: New Hampshire Home Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 112: Rhode Island Home Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 113: South Region U.S. Home Hemodialysis Machines Market: Regional Overview and Trends
TABLE 114: South Region U.S. Home Hemodialysis Machines Market, by State, 2021–2035 (US$ Billion)
TABLE 115: South Region U.S. Home Hemodialysis Machines Market, by Product Type and Technology Type, 2021–2035 (US$ Billion)
TABLE 116: Texas Home Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 117: Florida Home Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 118: Georgia Home Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 119: North Carolina Home Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 120: Tennessee Home Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 121: South Carolina Home Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 122: Alabama Home Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 123: Mississippi Home Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 124: Louisiana Home Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 125: Arkansas Home Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 126: Kentucky Home Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 127: Oklahoma Home Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 128: Virginia Home Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 129: Maryland Home Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 130: West Virginia Home Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 131: Delaware Home Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 132: District of Columbia Home Hemodialysis Machines Market Analysis and Forecast, 2021–2035
TABLE 133: Midwest Region U.S. Home Hemodialysis Machines Market: Regional Overview and Trends
TABLE 134: Midwest Region U.S. Home Hemodialysis Machines Market, by State, 2021–2035 (US$ Billion)
TABLE 135: Midwest Region U.S. Home Hemodialysis Machines Market, by Product Type and Technology Type, 2021–2035 (US$ Billion)
TABLE 136: Illinois Home Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 137: Ohio Home Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 138: Michigan Home Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 139: Minnesota Home Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 140: Indiana Home Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 141: Wisconsin Home Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 142: Missouri Home Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 143: Iowa Home Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 144: Kansas Home Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 145: Nebraska Home Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 146: North Dakota Home Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 147: South Dakota Home Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 148: U.S. Home Hemodialysis Machines Market: Competitive Landscape Snapshot, 2025
TABLE 149: U.S. Home Hemodialysis Machines Market: Key Company Market Share Analysis, 2025
TABLE 150: U.S. Home Hemodialysis Machines Market: Company Positioning Matrix
TABLE 151: U.S. Home Hemodialysis Machines Market: Machine Portfolio Benchmarking of Key Players
TABLE 152: U.S. Home Hemodialysis Machines Market: Usability, Training and Water Management Benchmarking
TABLE 153: U.S. Home Hemodialysis Machines Market: Connectivity and Remote Monitoring Benchmarking
TABLE 154: U.S. Home Hemodialysis Machines Market: Strategic Developments, Partnerships and Product Launches
TABLE 155: Fresenius Medical Care / NxStage Medical: Company Profile
TABLE 156: Outset Medical, Inc.: Company Profile
TABLE 157: Quanta Dialysis Technologies: Company Profile
TABLE 158: Baxter International Inc.: Company Profile
TABLE 159: B. Braun Medical Inc.: Company Profile
TABLE 160: Nipro Medical Corporation: Company Profile
TABLE 161: Asahi Kasei Medical Co., Ltd.: Company Profile
TABLE 162: Toray Medical Co., Ltd.: Company Profile
TABLE 163: Mozarc Medical: Company Profile
TABLE 164: Diality Inc.: Company Profile
TABLE 165: DaVita Inc.: Company Profile
TABLE 166: U.S. Renal Care: Company Profile
TABLE 167: Satellite Healthcare: Company Profile
TABLE 168: Northwest Kidney Centers: Company Profile
TABLE 169: Innovative Renal Care: Company Profile
TABLE 170: Dialyze Direct: Company Profile
TABLE 171: Concerto Renal Services: Company Profile
TABLE 172: Dialysis Clinic, Inc.: Company Profile
TABLE 173: Somatus, Inc.: Company Profile
TABLE 174: Interwell Health: Company Profile
TABLE 175: Strive Health: Company Profile
TABLE 176: Monogram Health: Company Profile
TABLE 177: Panoramic Health: Company Profile
TABLE 178: Evergreen Nephrology: Company Profile
TABLE 179: Rockwell Medical, Inc.: Company Profile
TABLE 180: U.S. Home Hemodialysis Machines Market: Future Market Scenario Analysis, 2026–2035
TABLE 181: U.S. Home Hemodialysis Machines Market: Home HHD Penetration Scenario Analysis
TABLE 182: U.S. Home Hemodialysis Machines Market: Disruptive Technologies Impact Matrix
TABLE 183: U.S. Home Hemodialysis Machines Market: Emerging Business Trends
TABLE 184: U.S. Home Hemodialysis Machines Market: Technology Adoption Curve, 2026–2035
TABLE 185: U.S. Home Hemodialysis Machines Market: Investment Prioritization and White-Space Matrix
TABLE 186: U.S. Home Hemodialysis Machines Market: Strategic Recommendations for Machine Manufacturers
TABLE 187: U.S. Home Hemodialysis Machines Market: Strategic Recommendations for Dialysis Organizations
TABLE 188: U.S. Home Hemodialysis Machines Market: Strategic Recommendations for Health Systems and Nephrology Practices
TABLE 189: U.S. Home Hemodialysis Machines Market: Strategic Recommendations for Investors and New Entrants
TABLE 190: U.S. Home Hemodialysis Machines Market: Go-to-Market and Regional Entry Strategy
TABLE 191: U.S. Home Hemodialysis Machines Market: Product Positioning and Portfolio Expansion Guidance
TABLE 192: U.S. Home Hemodialysis Machines Market: Scope and Market Definition Limitation
TABLE 193: U.S. Home Hemodialysis Machines Market: Data Use and Historical Data Limitation
TABLE 194: U.S. Home Hemodialysis Machines Market: Forecasting and State-Level Estimation Limitation
TABLE 195: U.S. Home Hemodialysis Machines Market: Legal and Third-Party Data Disclaimer

List of Figures

FIGURE 1: U.S. Home Hemodialysis Machines Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: U.S. Home Hemodialysis Machines Market Ecosystem
FIGURE 4: Stakeholder Analysis
FIGURE 5: Market Revenue Boundary and Scope Framework
FIGURE 6: U.S. Home Hemodialysis Machines Market Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 7: U.S. Home Hemodialysis Machines Market Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 8: U.S. Home Hemodialysis Machines Market Year-wise Growth Curve, 2021–2035
FIGURE 9: U.S. Home HHD Installed-Base and Penetration Trend
FIGURE 10: Market Attractiveness Analysis
FIGURE 11: Market Dynamics
FIGURE 12: Innovation & Patent Landscape, 2021–2025
FIGURE 13: Home Hemodialysis Clinical Workflow Economics Framework
FIGURE 14: Provider Machine Procurement and Placement Decision Framework
FIGURE 15: Home Versus In-Center Hemodialysis Economics Framework
FIGURE 16: Home HHD Patient Conversion Funnel
FIGURE 17: Home HHD Training and Retention Framework
FIGURE 18: PESTEL Analysis
FIGURE 19: Porter’s Five Forces Analysis
FIGURE 20: Value Chain Analysis
FIGURE 21: Supply Chain Analysis
FIGURE 22: Connected Home Dialysis Technology Landscape
FIGURE 23: FDA and CMS Regulatory-Reimbursement Framework
FIGURE 24: Product Type Segment Market Share Analysis, 2025 & 2035
FIGURE 25: Product Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 26: Portable & Compact Home Hemodialysis Machines Market Trend, 2021–2035
FIGURE 27: Integrated Water-Purification Home Hemodialysis Systems Market Trend, 2021–2035
FIGURE 28: Conventional Home-Configured Hemodialysis Machines Market Trend, 2021–2035
FIGURE 29: Modular and High-Flow Home Hemodialysis Systems Market Trend, 2021–2035
FIGURE 30: Treatment Regimen Segment Market Share Analysis, 2025 & 2035
FIGURE 31: Treatment Regimen Segment Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 32: Frequent / Short-Daily Home Hemodialysis Market Trend, 2021–2035
FIGURE 33: Conventional Three-Times-Weekly Home Hemodialysis Market Trend, 2021–2035
FIGURE 34: Nocturnal and Extended-Hour Home Hemodialysis Market Trend, 2021–2035
FIGURE 35: Flexible and Hybrid Home Hemodialysis Prescriptions Market Trend, 2021–2035
FIGURE 36: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 37: End User Segment Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 38: Large Dialysis Provider Home Programs Market Trend, 2021–2035
FIGURE 39: Integrated Health Systems and Hospital Networks Market Trend, 2021–2035
FIGURE 40: Nephrology and Value-Based Kidney Care Organizations Market Trend, 2021–2035
FIGURE 41: Specialized Home Dialysis Providers Market Trend, 2021–2035
FIGURE 42: Technology Type Segment Market Share Analysis, 2025 & 2035
FIGURE 43: Technology Type Segment Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 44: Cartridge-Based Home Hemodialysis Systems Market Trend, 2021–2035
FIGURE 45: Integrated Water and On-Demand Dialysate Systems Market Trend, 2021–2035
FIGURE 46: Connected and Software-Enabled Home Hemodialysis Systems Market Trend, 2021–2035
FIGURE 47: Procurement & Deployment Model Segment Market Share Analysis, 2025 & 2035
FIGURE 48: Procurement & Deployment Model Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 49: Home HHD Machine Procurement and Deployment Model Framework
FIGURE 50: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 51: Regional Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 52: U.S. Regional Home Hemodialysis Penetration and Installed-Base Comparison
FIGURE 53: West Region U.S. Home Hemodialysis Machines Market Share and Competitive Landscape, 2025
FIGURE 54: West Region Market Share Analysis by State, 2025
FIGURE 55: West Region Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 56: California Home Hemodialysis Machines Market Size and Trend, 2021–2035
FIGURE 57: Washington Home Hemodialysis Machines Market Size and Trend, 2021–2035
FIGURE 58: Arizona Home Hemodialysis Machines Market Size and Trend, 2021–2035
FIGURE 59: Colorado Home Hemodialysis Machines Market Size and Trend, 2021–2035
FIGURE 60: Oregon Home Hemodialysis Machines Market Size and Trend, 2021–2035
FIGURE 61: Utah Home Hemodialysis Machines Market Size and Trend, 2021–2035
FIGURE 62: Nevada Home Hemodialysis Machines Market Size and Trend, 2021–2035
FIGURE 63: New Mexico Home Hemodialysis Machines Market Size and Trend, 2021–2035
FIGURE 64: Idaho Home Hemodialysis Machines Market Size and Trend, 2021–2035
FIGURE 65: Montana Home Hemodialysis Machines Market Size and Trend, 2021–2035
FIGURE 66: Wyoming Home Hemodialysis Machines Market Size and Trend, 2021–2035
FIGURE 67: Alaska Home Hemodialysis Machines Market Size and Trend, 2021–2035
FIGURE 68: Hawaii Home Hemodialysis Machines Market Size and Trend, 2021–2035
FIGURE 69: Northeast Region U.S. Home Hemodialysis Machines Market Share and Competitive Landscape, 2025
FIGURE 70: Northeast Region Market Share Analysis by State, 2025
FIGURE 71: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 72: New York Home Hemodialysis Machines Market Size and Trend, 2021–2035
FIGURE 73: Massachusetts Home Hemodialysis Machines Market Size and Trend, 2021–2035
FIGURE 74: New Jersey Home Hemodialysis Machines Market Size and Trend, 2021–2035
FIGURE 75: Pennsylvania Home Hemodialysis Machines Market Size and Trend, 2021–2035
FIGURE 76: Connecticut Home Hemodialysis Machines Market Size and Trend, 2021–2035
FIGURE 77: Maine Home Hemodialysis Machines Market Size and Trend, 2021–2035
FIGURE 78: Vermont Home Hemodialysis Machines Market Size and Trend, 2021–2035
FIGURE 79: New Hampshire Home Hemodialysis Machines Market Size and Trend, 2021–2035
FIGURE 80: Rhode Island Home Hemodialysis Machines Market Size and Trend, 2021–2035
FIGURE 81: South Region U.S. Home Hemodialysis Machines Market Share and Competitive Landscape, 2025
FIGURE 82: South Region Market Share Analysis by State, 2025
FIGURE 83: South Region Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 84: Texas Home Hemodialysis Machines Market Size and Trend, 2021–2035
FIGURE 85: Florida Home Hemodialysis Machines Market Size and Trend, 2021–2035
FIGURE 86: Georgia Home Hemodialysis Machines Market Size and Trend, 2021–2035
FIGURE 87: North Carolina Home Hemodialysis Machines Market Size and Trend, 2021–2035
FIGURE 88: Tennessee Home Hemodialysis Machines Market Size and Trend, 2021–2035
FIGURE 89: South Carolina Home Hemodialysis Machines Market Size and Trend, 2021–2035
FIGURE 90: Alabama Home Hemodialysis Machines Market Size and Trend, 2021–2035
FIGURE 91: Mississippi Home Hemodialysis Machines Market Size and Trend, 2021–2035
FIGURE 92: Louisiana Home Hemodialysis Machines Market Size and Trend, 2021–2035
FIGURE 93: Arkansas Home Hemodialysis Machines Market Size and Trend, 2021–2035
FIGURE 94: Kentucky Home Hemodialysis Machines Market Size and Trend, 2021–2035
FIGURE 95: Oklahoma Home Hemodialysis Machines Market Size and Trend, 2021–2035
FIGURE 96: Virginia Home Hemodialysis Machines Market Size and Trend, 2021–2035
FIGURE 97: Maryland Home Hemodialysis Machines Market Size and Trend, 2021–2035
FIGURE 98: West Virginia Home Hemodialysis Machines Market Size and Trend, 2021–2035
FIGURE 99: Delaware Home Hemodialysis Machines Market Size and Trend, 2021–2035
FIGURE 100: District of Columbia Home Hemodialysis Machines Market Trend, 2021–2035
FIGURE 101: Midwest Region U.S. Home Hemodialysis Machines Market Share and Competitive Landscape, 2025
FIGURE 102: Midwest Region Market Share Analysis by State, 2025
FIGURE 103: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 104: Illinois Home Hemodialysis Machines Market Size and Trend, 2021–2035
FIGURE 105: Ohio Home Hemodialysis Machines Market Size and Trend, 2021–2035
FIGURE 106: Michigan Home Hemodialysis Machines Market Size and Trend, 2021–2035
FIGURE 107: Minnesota Home Hemodialysis Machines Market Size and Trend, 2021–2035
FIGURE 108: Indiana Home Hemodialysis Machines Market Size and Trend, 2021–2035
FIGURE 109: Wisconsin Home Hemodialysis Machines Market Size and Trend, 2021–2035
FIGURE 110: Missouri Home Hemodialysis Machines Market Size and Trend, 2021–2035
FIGURE 111: Iowa Home Hemodialysis Machines Market Size and Trend, 2021–2035
FIGURE 112: Kansas Home Hemodialysis Machines Market Size and Trend, 2021–2035
FIGURE 113: Nebraska Home Hemodialysis Machines Market Size and Trend, 2021–2035
FIGURE 114: North Dakota Home Hemodialysis Machines Market Size and Trend, 2021–2035
FIGURE 115: South Dakota Home Hemodialysis Machines Market Size and Trend, 2021–2035
FIGURE 116: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 117: Company Positioning Matrix
FIGURE 118: Key Player Home Hemodialysis Machine Portfolio Benchmarking
FIGURE 119: Machine Usability, Training and Workflow Benchmarking
FIGURE 120: Water Management and Dialysate Technology Benchmarking
FIGURE 121: Connectivity and Remote Monitoring Capability Benchmarking
FIGURE 122: Strategic Developments, Partnerships and Product Launches
FIGURE 123: U.S. Home Hemodialysis Machine Innovation Roadmap
FIGURE 124: Future Market Scenario Analysis, 2026–2035
FIGURE 125: Home Hemodialysis Penetration Scenario Analysis, 2026–2035
FIGURE 126: Disruptive Technologies Impact Matrix
FIGURE 127: Connected Home Dialysis Technology Adoption Roadmap
FIGURE 128: Emerging Business Trends Matrix
FIGURE 129: Investment Prioritization and Market White-Space Matrix
FIGURE 130: Strategic Growth Roadmap for U.S. Home Hemodialysis Machine Companies
FIGURE 131: Home HHD Patient Training and Retention Strategy Framework
FIGURE 132: Go-to-Market and Regional Expansion Strategy Framework
FIGURE 133: Product Positioning and Portfolio Expansion Framework
FIGURE 134: Report Scope, Forecasting Limitation and Disclaimer Framework